Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia Article

(2018). Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia . Clinical Microbiology and Infection (CMI), 24(5), 10.1016/j.cmi.2017.08.029

sustainable development goals

publication date

  • May 1, 2018

published in

keywords

  • Antimicrobial peptides
  • Cationic peptides
  • HOST-DEFENSE
  • INFECTION
  • Infectious Diseases
  • LL37
  • Life Sciences & Biomedicine
  • MOLECULAR EPIDEMIOLOGY
  • PSEUDOMONAS-AERUGINOSA
  • Pneumonia
  • TRYPTOPHAN

Digital Object Identifier (DOI)

volume

  • 24

issue

  • 5